Dr. Russell Chan is the CEO of Hai Kang Life Corporation (HKLife) and a senior consultant at COCHE (Hong Kong Center for Cerebro-cardiovascular Health Engineering). He obtained his B.Eng. in biomedical engineering and Ph.D. in electrical and electronic engineering from The University of Hong Kong (HKU). He was a post-doctoral research fellow at Stanford University in Neurology and Neurological Sciences, and New York University in Neuroscience, Tech4Health, and Ophthalmology. He was the co-founder and Chief Technology Officer (CTO) of a Forbes Asia 100 to Watch Startup.
Dr. Chan is an elected Junior Fellow of International Society of Magnetic Resonance in Medicine (ISMRM), a prestigious and highly selective award for young scientists from the leading global MRI society. He is the ex-co member and R&D focus group lead of the Hong Kong Institute of Engineers (HKIE) Biomedical Division. He is the founding Vice-Chair of the Young Member Section and a Young Fellow at the Hong Kong Academy of Engineering Sciences (HKAES). He is the Vice President of Hong Kong Biotechnology Organization (HKBIO), and Vice President of the Hong Kong International Biotechnology Convention (BIOHK).
- CEO, Hai Kang Life Corporation (HKLife)
- Senior Consultant, Hong Kong Center for Cerebro-cardiovascular Health Engineering (COCHE)
- Ex-co and , Hong Kong Institute of Engineers (HKIE) Biomedical Division
- Founding Vice-Chair of Young Member Section and Young Fellow, Hong Kong Academy of Engineering Sciences (HKAES)
- Vice President, Hong Kong Biotechnology Organization (HKBIO)
- Vice President, Hong Kong International Biotechnology Convention (BIOHK)